445 - 456 of 7680 results

FAQ for e-Cigarettes and Vaping: The Good, the Bad, and the Ugly

e-Cigarettes were 1st introduced to the US market in 2007, essentially to help smokers stop smoking tobacco-based cigarettes. There is some evidence that, for some adults, it may be beneficial to assist with smoking cessation. However, the use of e-Cigarettes and vaping (referred to as ENDS – electronic nicotine delivery systems), has increased significantly, specifically in the US teen population. The FDA and AAP have addressed the concerns surrounding e-Cigarettes and vaping in both regulations and policy statements. Join us as we discuss the latest evidence, potential benefits, and public health concerns regarding e-Cigarettes and vaping.Guest: Susan Feeney, DNP, FNP-BC, NP-C

e-Cigarettes were 1st introduced to the US market in 2007, essentially to help smokers stop smoking tobacco-based cigarettes. There is some evidence that, for some adults, it may be beneficial to assist with smoking cessation. However, the use of e-Cigarettes and vaping (referred to as ENDS – electronic nicotine delivery systems), has increased significantly, specifically in the US teen population. The FDA and AAP have addressed the concerns surrounding e-Cigarettes and vaping in both regulations and policy statements. Join us as we discuss the latest evidence, potential benefits, and public health concerns regarding e-Cigarettes and vaping.


0.5 CME CREDIT

An elevated fasting blood glucose (FBG) is the hall mark of prediabetes. Fasting blood glucose increases approximately 1 mg/dl per year as a prediabetic. While it can take years for a person to develop type 2 diabetes from prediabetes, weight gain, sedentary lifestyle, illness, or stress, can accelerate this process. This presentation will discuss the prevalence and progression of prediabetes, as well as the most effective strategies to prevent the development of type 2 diabetes.


0.75 CME CREDIT

Treating Patients with Anemia of CKD

0.75 CME
0.70 AANP | 0.70 Pharmacology

The goal of this activity is to understand the challenges of individualized management of CKD-related anemia with a focus on strategies for making treatment decisions and patient-centric treatment plans. Unmet needs of treating anemia of CKD will also be discussed.


0.75 CME CREDIT

This lecture will provide a comprehensive overview of contraceptive options for women of child-bearing ages. The significance and impact of prescribing practices on women will be discussed highlighting the importance of reproductive planning in all female patients with childbearing potential. Principles of effective contraceptive counseling will be outlined. Risks, benefits and medical indications for various contraceptive methods will be reviewed. Initiation and management of noncompliance with various contraceptive methods will also be discussed. A practical approach to management of contraceptive side effects will be discussed as well as risk/benefit assessments in choice of most appropriate contraceptive options.


0.5 CME CREDIT

Cardiovascular risk factors leading to the leading causes of death in the United States have their origins in the pediatric age group. This session is intended to give primary care providers a high level view of screening and management for cardio-metabolic risk factors in the pediatric age group based on the most up-to-date guidelines.


0.75 CME CREDIT

With the widespread accessibility to information on the Internet, much of which is not necessarily evidence-based, it appears that patients are more frequently consulting with their caregivers about vague somatic complaints that they think are due to exposure to various microbial organisms. Chronic Lyme disease has become a favorite disease due to some well-publicized celebrities announcing that they are suffering from this disorder. Patients also complain from the effects of mold exposure (“Toxic mold”), parasite infestations (delusions of parasitosis or Morgellon disease), among others. Patients can be very insistent, demanding therapies that are not supported by evidence. This presentation will assist practitioners as to how to appropriately diagnose and counsel patients about these various disorders.


1 CME CREDIT

Listen for a summary of current guidelines for breast cancer screening that will help you provide the most appropriate screening for your patients based on their individual risk.


0.75 CME CREDIT

This activity provides a succinct but comprehensive review of pediatric and adult in-office fracture management for primary care providers.


Group of Primary Care Doctors Smiling

PrimaryCareNOW: A Pri-Med Virtual Conference. Earn up to 6.50 CME/CE credits in one day during this virtual CME conference.


0.5 CME CREDIT

In this clinical coffee break, cardiologist Ty Gluckman and endocrinologist Archana Sadhu will explain why glucagon like peptide-1 receptor agonists (GLP-1 RA) are becoming increasingly prominent in diabetes algorithms and cardiovascular risk reduction. Faculty will review the clinical trial data on this class of medications as well as the mechanisms by which GLP-1 RA provide cardiovascular benefit. You will have the opportunity to engage with this activity, viewing resources and testing your knowledge with interactive questions and cases.


1 CME CREDIT

During this clinical coffee break, Dr. M. Susan Burke, and Elizabeth Haftel, a clinical pharmacist and certified diabetes educator, will discuss practical strategies for using GLP-1 receptor agonists in your patients with diabetes. They will discuss how this class of medications can benefit certain patients. To illustrate the process, faculty will walk through a patient case. You will have the opportunity to engage with this activity, view resources and test your knowledge with interactive questions.


Primary Care Pulse: Live on November 17, 2020

Pri-Med's new weekly CME/CE web series, Primary Care Pulse, features live conversations about timely topics and concerns facing primary care clinicians.